Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
TENAX THERAPEUTICS, INC. See All Filings	D	2024-08-23 16:31:39 UTC
Amount To Be Raised $174,999,993 Associated Brokers / Dealers Leerink Partners LLC, Guggenheim Securities, LLC, William Blair & Company, L.L.C., and Roth Capital Partners, LLC CIK Number 0000034956 Filed Document 0001578563-24-000391 Exclusions or Exemptions 506b Accepted Date 2024-08-23 16:31:39 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Equity
TENAX THERAPEUTICS, INC. See All Filings	D	2022-06-01 17:11:23 UTC
Amount To Be Raised $8,000,000 Associated Brokers / Dealers N/A CIK Number 0000034956 Filed Document 0001578563-22-000019 Exclusions or Exemptions 506b Accepted Date 2022-06-01 17:11:23 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
TENAX THERAPEUTICS, INC. See All Filings	D	2021-07-20 17:00:50 UTC
Amount To Be Raised $9,999,998 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0000034956 Filed Document 0001654954-21-008084 Exclusions or Exemptions 506b Accepted Date 2021-07-20 17:00:50 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
TENAX THERAPEUTICS, INC. See All Filings	D	2020-07-22 17:00:11 UTC
Amount To Be Raised $5,173,587 Associated Brokers / Dealers H.C. Wainwright & Co., LLC and Ladenburg Thalmann & Co. Inc. CIK Number 0000034956 Filed Document 0001654954-20-007918 Exclusions or Exemptions 506b Accepted Date 2020-07-22 17:00:11 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
TENAX THERAPEUTICS, INC. See All Filings	D	2020-03-26 19:55:56 UTC
Amount To Be Raised $317,167 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0000034956 Filed Document 0001654954-20-003352 Exclusions or Exemptions 506b Accepted Date 2020-03-26 19:55:56 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
OXYGEN BIOTHERAPEUTICS, INC. See All Filings	D	2013-11-27 00:00:00 UTC
Amount To Be Raised $6,579,122 Associated Brokers / Dealers N/A CIK Number 0000034956 Filed Document 0001354488-13-006674 Exclusions or Exemptions 506b Accepted Date 2013-11-27 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NORTH CAROLINA Revenue or Assets $$1,000,001 - $5,000,000 Type of Security Equity